EGFR and breast cancer: Several proteins, including epidermal growth factor receptor (EGFR), survival apoptosis inhibitor, carcinogenic marker CD24, localized adhesive kinase (FAK) and surface cell proteoglycan glycan-1, are significantly overexpressed in the breast cancer patient’s serum-derived exosomes as compared to the healthy donors [119,170].